A new protocol—HEART Pathway—can identify low-risk emergency department patients with chest pain who can be discharged without stress testing or angiography, according to results of a Sept. 28 study published in Circulation.

Intravascular ultrasound (IVUS)-guided stent implantation produced better clinical outcomes for heart patients compared to a conventional angiography-guided method, said researchers this week at the Transcatheter Cardiovascular Therapeutics (TCT) meeting in San Diego, California.

With additional testing for nonobstructive coronary artery disease (CAD), researchers effectively diagnosed microvascular and/or vasospastic angina—as well as non-cardiac related chest pain—and used that information to guide therapy decisions and significantly improve angina and quality-of-life outcomes.

INSIGHTEC®,a global medical technology innovator of incisionless surgery, today announced that the U.S. Food and Drug Administration (FDA) has approved Exablate Neuro™ compatibility for the state-of-the-art MRI Scanners Magnetom Skyra, Prisma and Prisma[fit] from Siemens Healthineers to treat patients with essential tremor (ET).

Radiology staff at VCU Medical Center, the comprehensive care center of VCU Health located in downtown Richmond, Virginia, perform approximately 160,000 imaging procedures a year with six CARESTREAM DRX-Evolution Systems, nine CARESTREAM DRX-Revolution Mobile X-ray Systems, and three room-based imaging systems that have been converted to DR with CARESTREAM DRX-1 in-room retrofits and the company’s DRX detectors.

Fractional flow reserve (FFR) measured using coronary angiogram achieved greater diagnostic accuracy compared to invasive pressure-wire, according to a 10-center study published in Circulation.

Intelerad Medical Systems™, a leader in enterprise workflow solutions, is pleased to announce that following the retirement of Randall Oka, its board of directors has appointed Paul Lepage as its new president and chief executive officer.

Results from the BIONYX Trial found the Resolute Onyx stent provided better x-ray visibility compared to Orsiro, an established cobalt-chromium strut stent, according to findings presented Monday, Sept. 24, at the Transcatheter Cardiovascular Therapeutics (TCT) symposium in San Diego.